Aberrant expression of connexin 26 is associated with lung metastasis of colorectal cancer

Clinical Cancer Research

Volumn 14, Issue 3, 2008, Pages 677-684

  Ezumi, Koji ^a   Yamamoto, Hirofumi ^a,e   Murata, Kohei ^c   Higashiyama, Masahiko ^d   Damdinsuren, Bazarragchaa ^a   Nakamura, Yurika ^a   Kyo, Naganori ^a   Okami, Jiro ^d   Chew, Yee Ngan ^a   Takemasa, Ichiro ^a   Ikeda, Masataka ^a   Sekimoto, Mitsugu ^a   Matsuura, Nariaki ^a   Nojima, Hiroshi ^b   Monden, Morito ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Suita Municipal Hospital   (Japan)

^d OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^e OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 26;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL MEMBRANE; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CONNEXINS; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION;

EID: 38949150800     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1184     Document Type: Article

References (43)

1. Kumar NM, Gilula NB. The gap junction communication channel. Cell 1996;84:381-8.
2. Charles AC, Naus CC, Zhu D, Kidder Gm, Dirksen ER, Sanderson MJ. Intercellular calcium signaling via gap junctions in glioma cells. J Cell Biol 1992;118:195-201.
3. Goodenough DA, Goliger JA, Paul DL. Connexins, connexons, and intercellular communication. Annu Rev Biochem 1996;65:475-502.
4. Willecke K, Eiberger J, Degen J, et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002;383:725-37.
5. Lee SW, Tomasetto C, Paul D, Keyomarsi K, Sager R. Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J Cell Biol 1992;118:1213-21.
6. Janssen-Timmen U, Traub O, Dermietzel R, Rabes HM, Willecke K. Reduced number of gap junctions in rat hepatocarcinomas detected by monoclonal antibody. Carcinogenesis 1986;7:1475-82.
7. Mesnil M. Connexins and cancer. Biol Cell 2002;94:493-500.
8. Asamoto M, Toriyama-Baba T, Krutovskikh V, Cohen SM, Tsuda H. Enhanced tumorigenicity of rat bladder squamous cell carcinoma cells after abrogation of gap junctional intercellular communication. Jpn J Cancer Res 1998;89:481-6.
9. Eghbali B, Kessler JA, Reid LM, Roy C, Spray DC. Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc Natl Acad Sci U S A 1991;88:10701-5.
10. Muramatsu A, Iwai M, Morikawa T, et al. Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells. Carcinogenesis 2002;23:351-8.
11. Tanaka M, Grossman HB. Connexin 26 gene therapy of human bladder cancer: induction of growth suppression, apoptosis, and synergy with cisplatin. Hum Gene Ther 2001;12:2225-36.
12. Pfeffer F, Koczan D, Adam U, et al. Expression of connexin26 in islets of Langerhans is associated with impaired glucose tolerance in patients with pancreatic adenocarcinoma. Pancreas 2004;29:284-90.
13. Villaret DB, Wang T, Dillon D, et al. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 2000;110:374-81.
14. Kanczuga-Koda L, Sulkowski S, Koda M, Sulkowska M. Alterations in connexin26 expression during colorectal carcinogenesis. Oncology 2005;68:217-22.
15. Tate AW, Lung T, Radhakrishnan A, Lim SD, Lin X, Edlund M. Changes in gap junctional connexin isoforms during prostate cancer progression. Prostate 2006;66:19-31.
16. Haass NK, Wladykowski E, kief S, Moll I, Brandner JM. Differential induction of connexins 26 and 30 in skin tumors and their adjacent epidermis. J Histochem Cytochem 2006;54:171-82.
17. Jamieson S, Going JJ, D'Arcy R, George WD. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. J Pathol 1998;184:37-43.
18. Kanczuga-Koda L, Sulkowski S, Lenczewski A, et al. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol 2006;59:429-33.
19. Ito A, Katoh F, Kataoka TR, et al. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest 2000;105:1189-97.
20. Ito A, Koma Y, Uchino K, et al. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis. Cancer Lett 2006;234:239-48.
21. Naoi Y, Miyoshi Y, Taguchi T, et al. Connexin 26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancer. Breast Cancer Res Treat 2007;106:11-7.
22. Yamamoto H, Kondo M, Nakamori S, et al. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis. Gastroenterology 2003;125:556-71.
23. Takemasa I, Yamamoto H, Sekimoto M, et al. Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. Cancer Res 2000;60:3043-50.
24. Ogawa M, Yamamoto H, Nagano H, et al. Hepatic expression of ANG2 RNA in metastatic colorectal cancer. Hepatology 2004;39:528-39.
25. Kondo M, Nagano H, Sakon M, et al. Expression of interferon α/β receptor in human hepatocellular carcinoma. Int J Oncol 2000;17:83-8.
26. Ander T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-51.
27. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
28. Kobayashi H, Mochizuki H, Sugihara K, et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery 2007;141:67-75.
29. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-5.
30. Ito A, Morita N, Miura D, et al. A derivative of oleamide potently inhibits the spontaneous metastasis of mouse melanoma BL6 cells. Carcinogenesis 2004;25:2015-22.
31. Gee J, Tanaka M, Grossman HB. Connexin 26 is abnormally expressed in bladder cancer. J Urol 2003;169:1135-7.
32. Torres LN, Matera JM, Vasconcellos CH, Avanzo JL, Hernandez-Blazquez FJ, Dagli ML. Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands. Ver Pathol 2005;42:633-41.
33. Morris VL, Schmidt EE, MacDonald IC, Groom AC, Chambers AF. Sequential steps in hematogenous metastasis of cancer cells studied by in vivo video-microscopy. Invasion Metastasis 1997;17:281-96.
34. Qin H, Shao Q, Curtis H, et al. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem 2002;277:29132-8.
35. Tanaka M, Grossman HB. Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells. Oncol Rep 2004;11:537-41.
36. Sulkowski S, Kanczuga-Koda L, Koda M, et al. Insulin-like growth factor-I receptor correlates with connexin 26 and Bcl-xL expression in human colorectal cancer. Ann N Y Acad Sci 2006;1090:265-75.
37. Miura D, Kida Y, Nojima H. Camellia oil andits distillate fractions effectively inhibit the spontaneous metastasis of mouse melanoma BL6 cells. FEBS Lett 2007;581:2541-8.
38. Yanagawa R, Furukawa Y, Tsunoda T, et al. Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray. Neoplasia 2001;3:395-401.
39. Yamasaki M, Takemasa I, Komori T, et al. The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer. Int J Oncol 2007;30:129-38.
40. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989;8:98-101.
41. Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer. Nat Rev Cancer 2007;7:79-94.
42. Ohba Y, Kanao Y, Morita N, et al. Oleamide derivatives suppress the spontaneous metastasis by inhibiting connexin 26. Int J Cancer 2007;121:2801-8.
43. Akasu T, Yamaguchi T, Fujimoto Y, et al. Abdominal sacral resection for posterior pelvic recurrence of rectal carcinoma: analyses of prognostic factors and recurrence patterns. Ann Surg Oncol 2007;14:74-83.